Serum interleukin-17 (IL-17) in chronic periodontitis patients

Erry Mochamad Arief, Marina binti Mubin, Siti Lailatul Akmar Zainuddin, Nurul Asma Abdullah, Basaruddin Ahmad

Abstract


Introduction: Explorations into the periodontal medicine relationship have discovered interleukin-17 (IL-17) cytokine as one of the pro-inflammatory mediators that play a crucial role in the initiation and progression of the chronic periodontal disease. This case and control study aimed to compare the serum IL-17 concentration between chronic periodontitis and healthy subjects and to assess the relationship between the IL-17 serum and the clinical periodontal parameters in chronic periodontitis patients. Methods: This study was a case-control study. The subjects were selected using purposive sampling method. The periodontal screening assessment in the Family Treatment Center and Postgraduate Dental Clinic, Universiti Sains Malaysia Hospital. A total of 55 samples who fit with the inclusion and exclusion study criteria of full-mouth clinical periodontal records together with blood serums were obtained from 28 chronic periodontitis patients and from 27 healthy subjects. The concentration of IL-17 cytokine in serum was measured using ELISA test. Results: Subjects with periodontal disease presented significantly worse clinical parameters (p<0.001) compared to control. The level of serum IL-17 concentration was significantly higher (p=0.026) in chronic periodontitis subjects 3.6 (1.03) pg/mL compared to the control 3.1 (0.70) pg/mL. Conclusions: There was no correlation between the level of IL-17 concentration in the serum and clinical periodontal parameters.


Keywords


Interleukin-17, chronic periodontitis, cytokine

Full Text:

PDF

References


Kinane DF, Lindhe J, Trombelli L. Chronic Periodontitis. In: Lindhe J, Lang NP, Karring T, editors. Clinical Periodontology and Implant Dentisry. 5th ed. Oxford (UK): Wiley and Sons Ltd.; 2008. p. 420-7.

Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000. Jun 2010;53: p. 70-88. DOI: 10.1111/j.1600-0757.2010.00357.x.

Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. May 1999;103(9): p. 1345-52. DOI: 10.1172/JCI5703.

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. Apr 1999;5(2): p. 101-4. DOI: 10.1177/135245859900500206.

Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol. Apr 2005;32(4): p. 383-9. DOI: 10.1111/j.1600-051X.2005.00684.x.

Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol. Aug 2007;78(8): p. 1545-50. DOI: 10.1902/jop.2007.060458.

Pradeep AR, Hadge P, Chowdhry S, Patel S, Happy D. Exploring the role of Th1 cytokines: interleukin-17 and interleukin-18 in periodontal health and disease. J Oral Sci. Jun 2009;51(2): p. 261-6.

Duarte PM, da Rocha M, Sampaio E, Mestnik MJ, Feres M, Figueiredo LC, et al. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol. Jul 2010;81(7): p. 1056-63. DOI: 10.1902/jop.2010.090732.

Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. Apr 1990;11(2): p. 116-28.

Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res. Sep 2010;89(9): p. 943-7. DOI: 10.1177/0022034510369297.

Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol. Jun 2007;78(6): p. 1083-93. DOI: 10.1902/jop.2007.060392.

Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. Dec 1995;155(12): p. 5483-6.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. Nov 27 2006;203(12): p. 2673-82. DOI: 10.1084/jem.20061775.

Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol. Jan 2004;75(1): p. 37-43. DOI: 10.1902/jop.2004.75.1.37.

Ozcaka O, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res. Oct 2011;46(5): p. 592-8. DOI: 10.1111/j.1600-0765.2011.01377.x.




DOI: https://doi.org/10.24198/pjd.vol29no3.14663

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Padjadjaran Journal of Dentistry

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 Visitor Stat

Creative Commons License
Padjadjaran Journal of Dentistry is licensed under a Creative Commons Attribution 4.0 International License